Legislation - HB0417

Prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine product or xylazine product unless the purchaser provides proof the intended use is for institutional, veterinary, or scientific purposes; prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine or xylazine product to an individual under the age of 21 years; requiring a retailer that prepares, distributes, sells, or exposes for sale a medetomidine or xylazine product to maintain certain records; etc.

Committees

Original:: Health

Details

Cross-filed with: SB0435

Introduced in a prior session as: HB1109 Session: 2025 Regular Session

Bill File Type: Regular

Effective Date(s): October 1, 2026

History

Legislation History
Chamber House Calendar Date 1/22/2026 Legislative Date 1/22/2026 Action First Reading Health Proceedings
Chamber Calendar Date Legislative Date Action Text - First - Public Health - Medetomidine and Xylazine Consumer Protection Act Proceedings
Chamber House Calendar Date 1/22/2026 Legislative Date 1/22/2026 Action Hearing 2/10 at 2:00 p.m. Proceedings

Chamber	Calendar Date	Legislative Date	Action
House	1/22/2026	1/22/2026	First Reading Health
			Text - First - Public Health - Medetomidine and Xylazine Consumer Protection Act
House	1/22/2026	1/22/2026	Hearing 2/10 at 2:00 p.m.

File Code

Subjects

Statutes